|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
8/15/2012 8:01:20 AM
Two years ago, the University of South Florida intervened in a rather complicated piece of litigation involving the Alzheimer’s Institute of America and several drugmakers, as well as the University of Pennsylvania, over the rights to various patents. At the time, the institute alleged that the drugmakers, which included Elan and Eli Lilly, were developing and using drugs for which fees were not being paid. And so did the University of South Florida. And so, one of the various lawsuits went to trial in Pennsylvania eariler this year and a jury determined that the University of South Florida did, indeed, hold various patent rights. To settle matters, the school and Elan reached a deal that called for the drugmaker to make a $175,000 payment (read this), but the school alleges Elan never made good and has indicated it has not plans to do so, according to a new lawsuit.
|
|
|
|
|
|
|
|
|
|
|